University of Alabama: Study - Pembrolizumab Improves Outcomes for Endometrial Cancer Treatment
May 09, 2023
May 09, 2023
BIRMINGHAM, Alabama, May 9 (TNSjou) -- The University of Alabama issued the following news:
A new study published in the New England Journal of Medicine evaluated the effectiveness of adding Pembrolizumab to the current front-line standard of care for women with advanced primary or recurrent endometrial cancer.
The study's primary objective was to evaluate the effectiveness of adding Pembrolizumab to chemotherapy as a treatment for women diagnosed with advanced primary . . .
A new study published in the New England Journal of Medicine evaluated the effectiveness of adding Pembrolizumab to the current front-line standard of care for women with advanced primary or recurrent endometrial cancer.
The study's primary objective was to evaluate the effectiveness of adding Pembrolizumab to chemotherapy as a treatment for women diagnosed with advanced primary . . .